Skip to content

Novanta

US · NOVT #1995 by market cap Listed 1970
143.64 -5.46 -3.66%
Live - 5344 symbols - heartbeat 471s ago · 2026-10-08 06:25
Pre-market 141.87 -1.23%
After-hours 143.64 0.00%
Overnight 143.00 -0.45%
Market cap
5.43B
P/B
3.36
EPS
1.47
Reader sentiment Are you bullish or bearish on NOVT?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Fair Value how this is computed

Near fair value
101.02 fair value ≈ 125.30 149.59
  • Implied fair-value range of 101.02-149.59, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is +14.6% above the average-multiple fair value of 125.30.

Valuation each multiple against its own 5-year range

P/B ratio 3.55 Cheap vs history 5th percentile
5-year average 7.83 · #17 of 32 in Scientific & Technical Instruments
P/E ratio 96.09 Expensive vs history 77th percentile
5-year average 85.24 · forward 63.01 · #16 of 18 in Scientific & Technical Instruments
P/S ratio 5.58 In line with history 34th percentile
5-year average 6.10 · forward 4.69 · #19 of 32 in Scientific & Technical Instruments

Vs. peers Scientific & Technical Instruments

Company Market cap P/E (TTM) P/B Div yield
Novanta (NOVT) 5.43B 90.91 3.36 0.00%
Coherent (COHR) 65.52B 81.20 6.01 0.00%
Keysight Technologies (KEYS) 64.93B 52.39 9.88 0.00%
Garmin (GRMN) 53.26B 28.50 5.90 1.36%
Teledyne Technologies (TDY) 28.01B 29.23 2.56 0.00%
MKS Inc (MKSI) 18.47B 43.50 6.18 0.34%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value140.74 Economic moatNarrow UncertaintyMedium

Trading 2.0% above Morningstar's fair value estimate.

Fair value

Novanta Inc receives a 3-star quantitative star rating, indicating our belief that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 7% premium over our quantitative fair value estimate of $140.74 per share; however, this estimate should be taken with a pinch of salt due to its medium uncertainty rating. We require the price/fair value ratio to move a certain amount before the star rating can change. This stability-enhancing buffer is in effect for this stock.

The company's valuation metrics decrease our estimated fair value. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of 28.7%, which sits in the bottom 30% globally. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which contributes to our view that shares are expensive.

The company's lack of profitability is an additional cause for concern. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. The firm's earnings yield of 1.9%, a core component of profitability, falls in the bottom 40% compared with peers globally. The earnings generated by the company relative to its share price is concerning, which further promotes our unfavorable price/fair value ratio.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance may signify a bull trap, in light of other detractors from our model.

Economic moat

The company's narrow quantitative moat rating indicates it could outearn its cost of capital and maintain robust margins for 10 years or longer. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.

By Quantitative Equity Report

Quote time 2026-10-08 06:25:34 · For reference only, not investment advice and not tailored to your situation.